ImmuCell

ImmuCell PP&E per Employee

The PP&E per Employee of ImmuCell (ICCC) as of Oct 21, 2026 is 419.68 M USD. In the previous year, PP&E per Employee was 383,599.05 USD — a change of 109,305.03% (higher).

PP&E per Employee

419.68 MUSD

YoY

109,305.03%

Last updated:

PP&E per Employee of ImmuCell is 2022 419.68 M USD. PP&E per Employee of ImmuCell was 2021 383,599.05 USD. It decreases by 109,305.03% higher compared to the previous year.

The ImmuCell PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2015
78,339.92 USD
Jan 1, 2016
134,880.73 USD
Jan 1, 2017
357,119.03 USD
Jan 1, 2018
356,541.78 USD
Jan 1, 2019
346,106.00 USD
Jan 1, 2020
383,223.78 USD
Jan 1, 2021
383,599.05 USD
Jan 1, 2022
419.68 M USD
The ImmuCell PP&E per Employee history
YEARPP&E per EmployeeYoY
419.68 MUSD+109,305.03%
383,599.05USD+0.10%
383,223.78USD+10.72%
346,106.00USD-2.93%
356,541.78USD-0.16%
357,119.03USD+164.77%
134,880.73USD+72.17%
78,339.92USD+49.02%
52,570.51USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ImmuCell Stock analysis

What does ImmuCell do? ImmuCell Corp is an American company that specializes in the development and marketing of veterinary products for the ruminant industry. It was originally founded in the late 1970s under the name PrioGene and initially focused on the development of diagnostics for tuberculosis and brucellosis in cattle. In the 1990s, the company changed its name to ImmuCell and shifted its focus to the development of products to support animal health. ImmuCell's business model is centered around the development, manufacturing, and sale of products to improve animal health. They offer a wide range of veterinary products, including immunoassays, vaccines, antibiotics, and complementary feeds. The company aims to improve animal health with minimal impact on the environment and works closely with veterinarians and industry experts. They have divisions dedicated to diagnostics, vaccines, and antibiotics, and their products can help identify and prevent diseases in livestock. Notable products include the LBC mastitis diagnostic and the Immu-PRIME spray for preventing umbilical infections in newborn calves. ImmuCell has established itself as a leading innovator in the animal health industry and has conducted clinical studies on the efficacy of their HO-VAX product. In conclusion, ImmuCell focuses on developing and marketing products to support animal health, with a commitment to improving the well-being of livestock. ImmuCell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ImmuCell stock

PP&E per Employee of ImmuCell is 419.68 M USD in 2022.

PP&E per Employee of ImmuCell changed from 383,599.05 USD to 419.68 M USD, representing a 109,305.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee ImmuCell since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's ImmuCell historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — ImmuCell

All Key Metrics — ImmuCell